CORC

浏览/检索结果: 共196条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy 期刊论文
2019, 卷号: 17, 期号: 1, 页码: 339
作者:  Han Xiaohong;  Han Ying;  Tan Qiaoyun;  Huang Yu;  Yang Jianliang
收藏  |  浏览/下载:18/0  |  提交时间:2020/01/03
Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: a meta-analysis 期刊论文
2019, 页码: e12829
作者:  Liu Shuxia;  Tan Qiaoyun;  Song Yuanyuan;  Shi Yuankai;  Han Xiaohong
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer 期刊论文
2019
作者:  Xing Puyuan;  Han Xiaohong;  Wang Sha;  Liu Yutao;  Yang Sheng
收藏  |  浏览/下载:21/0  |  提交时间:2020/01/03
A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients 期刊论文
2019
作者:  Jiang Shiyu;  Qin Yan;  Liu Peng;  Yang Jianliang;  Yang Sheng
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 36
作者:  Zhou, Ming;  Chen, Xiaoyuan;  Zhang, Hong;  Xia, Lin;  Tong, Xin
收藏  |  浏览/下载:29/0  |  提交时间:2020/01/03
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载:43/0  |  提交时间:2020/01/03
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma 期刊论文
2019, 卷号: 9, 页码: 556
作者:  Han, Xiaohong;  Tan, Qiaoyun;  Yang, Sheng;  Li, Junling;  Xu, Jianping
收藏  |  浏览/下载:19/0  |  提交时间:2020/01/03
Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China 期刊论文
2019, 卷号: 9, 期号: 5, 页码: e028589
作者:  Jiang, Shiyu;  Liu, Peng;  Yang, Sheng;  Yang, Jianliang;  Wu, Dawei
收藏  |  浏览/下载:10/0  |  提交时间:2020/01/03
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文
2019, 卷号: 110, 期号: 4, 页码: 1503-1503
作者:  Hu, Shaoxuan;  Song, Yuqin;  Sun, Xiuhua;  Su, Liping;  Zhang, Wei
收藏  |  浏览/下载:66/0  |  提交时间:2020/01/03
Clinicopathologic characteristics and outcome of patients with different EGFR mutations 期刊论文
2019, 卷号: 15, 期号: 3, 页码: 166-171
作者:  Zhou, Shengyu;  Hu, Xingsheng;  Wang, Yan;  Li, Junling;  Zhou, Liqiang
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace